Cargando…
Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders
The anticonvulsant topiramate not only decreases ethanol consumption in alcohol dependence (AD) but also may produce several adverse events including cognitive impairment. Zonisamide is a structurally related anticonvulsant that is a promising agent for the treatment of AD and may have greater toler...
Autores principales: | Knapp, Clifford M., Ciraulo, Domenic A., Sarid-Segal, Ofra, Richardson, Mark A., Devine, Eric, Streeter, Chris C., Oscar-Berman, Marlene, Surprise, Caitlin, Colaneri, Laurie, Putnam, Meghan, Waters, Megan, Richambault, Courtney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276485/ https://www.ncbi.nlm.nih.gov/pubmed/25427171 http://dx.doi.org/10.1097/JCP.0000000000000246 |
Ejemplares similares
-
Open Label Trial of the Tolerability and Efficacy of Zonisamide in the Treatment of Alcohol Dependence
por: Knapp, Clifford M., et al.
Publicado: (2010) -
Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014) -
Effect of topiramate and zonisamide on fMRI cognitive networks
por: Wandschneider, Britta, et al.
Publicado: (2017) -
Levetiracetam/topiramate: Drug ineffective: case report
Publicado: (2022) -
Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate
por: Hau Man, To Harmony, et al.
Publicado: (2017)